loteprednol etabonate
RxNorm concept 52177, ingredient (in).
- RxCUI
- 52177
- Term type
- Ingredient (IN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/52177 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- Alrex (BN, has tradename)
- Lotemax (BN, has tradename)
- Zylet (BN, has tradename)
- Inveltys (BN, has tradename)
- Eysuvis (BN, has tradename)
- loteprednol etabonate 5 MG/ML (SCDC, ingredient of)
- loteprednol etabonate 2 MG/ML (SCDC, ingredient of)
- loteprednol etabonate Ophthalmic Suspension (SCDF, ingredient of)
- loteprednol etabonate / tobramycin Ophthalmic Suspension (SCDF, ingredient of)
- loteprednol etabonate 0.005 MG/MG (SCDC, ingredient of)
- loteprednol etabonate Ophthalmic Ointment (SCDF, ingredient of)
- loteprednol etabonate / tobramycin Ophthalmic Product (SCDG, ingredient of)
- loteprednol etabonate Ophthalmic Product (SCDG, ingredient of)
- loteprednol etabonate Ophthalmic Gel (SCDF, ingredient of)
- loteprednol etabonate 10 MG/ML (SCDC, ingredient of)
- loteprednol etabonate 0.0038 MG/MG (SCDC, ingredient of)
- loteprednol etabonate 2.5 MG/ML (SCDC, ingredient of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 52177 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/52177 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 52177. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.